Jeff Yass’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-59,700
| Closed | -$199K | – | 10347 |
|
|
2017
Q2 | $199K | Sell |
59,700
-6,600
| -10% | -$27.4K | ﹤0.01% | 8300 |
|
|
2017
Q1 | $611K | Buy |
66,300
+27,600
| +71% | +$242K | ﹤0.01% | 6129 |
|
|
2016
Q4 | $298K | Sell |
38,700
-1,500
| -4% | -$13.8K | ﹤0.01% | 7986 |
|
|
2016
Q3 | $459K | Buy |
40,200
+7,600
| +23% | +$88.5K | ﹤0.01% | 6222 |
|
|
2016
Q2 | $401K | Sell |
32,600
-8,500
| -21% | -$103K | ﹤0.01% | 6492 |
|
|
2016
Q1 | $416K | Sell |
41,100
-100
| -0.2% | -$1.17K | ﹤0.01% | 6720 |
|
|
2015
Q4 | $929K | Sell |
41,200
-37,800
| -48% | -$775K | ﹤0.01% | 5558 |
|
|
2015
Q3 | $1.31M | Buy |
79,000
+28,300
| +56% | +$567K | ﹤0.01% | 5136 |
|
|
2015
Q2 | $1.14M | Buy |
50,700
+26,000
| +105% | +$641K | ﹤0.01% | 5933 |
|
|
2015
Q1 | $637K | Buy |
+24,700
| New | +$626K | ﹤0.01% | 6656 |
|
|
2014
Q4 | – | Sell |
-12,000
| Closed | -$227K | – | 10675 |
|
|
2014
Q3 | $227K | Buy |
+12,000
| New | +$241K | ﹤0.01% | 8467 |
|
Jeff Yass's OMED Position: Q2 2019 in Review
Jeff Yass sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 14,993 shares — an estimated $16K sold.
Jeff Yass first reported a position in OMED in Q4 2014 and held it in 12 quarters. The position peaked at $810K in Q1 2015. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.
- Jeff Yass reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
- Jeff Yass sold 14,993 OncoMed Pharmaceuticals, Inc. shares in Q2 2019, an estimated $16K.
- Jeff Yass first reported a position in OncoMed Pharmaceuticals, Inc. in Q4 2014 and held it in 12 quarters.
- Jeff Yass's OncoMed Pharmaceuticals, Inc. position peaked at $810K in Q1 2015.
- 0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.
Based on Susquehanna International Group's 13F filing for Q2 2019, filed 14 Aug 2019.